FDA Approved: CLOBAZAM — Supplemental Application (Camber Pharmaceuticals, Inc.)

View source ↗

Summary

FDA approves a supplemental application for CLOBAZAM (clobazam) submitted by Camber Pharmaceuticals, Inc. The action updates the regulatory status of CLOBAZAM.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epilepsy
• Lennox-gastaut Syndrome

Drugs mentioned

• CLOBAZAM (CLOBAZAM)

Snippet

SUPPL AP for CLOBAZAM (CLOBAZAM)